Reversible NB | Irreversible NB | p | |
n | 25 | 37 | |
Age | 44.6 ± 9.4 | 44.9 ± 11.2 | 0.915* |
Follow-up period (months), median (range) | 24 (12 - 54) | 28 (12 - 56) | 0.096* |
Stage | |||
I/II/III | 17/8/0 | 26/10/1 | 0.755** |
Adjuvant radiotherapy, n (%) | 13 (52) | 19 (51) | 0.960** |